Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
    • Contact
    • Offers
  • Biotech Companies
  • Database researchers
    • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News

Tag Archives: Type 2 diabetes

Poxel – diabetes drug development

Posted on 2015-05-15 by Biotech365

Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.

Poxel – diabetes drug development

poxel

Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged AMPK, AMPK activator, antidiabetic, Bruno Montanari, cholesterol, Cliff Bailey, diabetes, diabetes drug development, drug development, Fabrizio Andreelli, Gerd Bode, glimins, GLP-1, GLP-1 receptor, glucagon-like peptide-1, glycemia, hepatic glucose production, Imeglimin, insulin, insulin secretion, Khoso Baluch, Merck Serono, metabolic diseases, mitcohondrial respiration, muscle glucose uptake, Olivier Martinez, Poxel, Poxel - diabetes drug development, Raphaƫl Wisniewski, Richard Kender, tetrahydrotriazine, Thierry Hercend, Thomas Kuhn, triglycerides, Type 2 diabetes

Follow Biotech 365 !

Follow @Biotech365

Search on Biotech 365 :

Search for Protocols :

Search on PubMed :

Eminently : be paid for your your introductions! Jobs referrals, business connections, etc…

                      About us                       Terms                       Partners                       Contact                       Offers                       RSS feed - Biotech 365                      
Proudly powered by WordPress